Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
Inspire Medical Systems (NYSE: INSP) announced its upcoming participation in the UBS Global Healthcare Conference. The medical technology company, which specializes in minimally invasive solutions for obstructive sleep apnea, will present on Wednesday, November 13, 2024, at 11:00 a.m. Eastern Time.
The presentation will be available through a live webcast, with replay access remaining available for two weeks afterward in the Event Archive section of Inspire's Investor website.
Inspire Medical Systems (NYSE: INSP) ha annunciato la sua prossima partecipazione alla Conferenza Globale sulla Salute UBS. L'azienda di tecnologia medica, specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, presenterà mercoledì 13 novembre 2024, alle 11:00 ora orientale.
La presentazione sarà disponibile tramite una diretta streaming, con accesso alla registrazione disponibile per due settimane dopo nella sezione Archivio Eventi del sito web per investitori di Inspire.
Inspire Medical Systems (NYSE: INSP) anunció su próxima participación en la Conferencia Global de Salud de UBS. La empresa de tecnología médica, especializada en soluciones mínimamente invasivas para la apnea obstructiva del sueño, presentará el miércoles 13 de noviembre de 2024, a las 11:00 a.m. hora del este.
La presentación estará disponible a través de una transmisión en vivo, con acceso a la repetición disponible durante dos semanas después en la sección de Archivo de Eventos del sitio web para inversores de Inspire.
Inspire Medical Systems (NYSE: INSP)는 UBS 글로벌 헬스케어 콘퍼런스에 참가할 예정이라고 발표했습니다. 최소 침습 솔루션을 전문으로 하는 의료 기술 회사인 이곳은 폐쇄성 수면 무호흡증에 대해 발표할 예정이며, 발표는 2024년 11월 13일 수요일 동부 표준시 기준 오전 11시에 진행됩니다.
발표는 라이브 웹캐스트를 통해 제공되며, 이후 2주 동안 Inspire의 투자자 웹사이트 이벤트 아카이브 섹션에서 재생 접근이 가능합니다.
Inspire Medical Systems (NYSE: INSP) a annoncé sa prochaine participation à la Conférence Mondiale sur la Santé UBS. Cette entreprise de technologie médicale, spécialisée dans les solutions peu invasives pour l'apnée obstructive du sommeil, présentera le mercredi 13 novembre 2024, à 11h00 heure de l'Est.
La présentation sera disponible via un webcast en direct, avec un accès à la rediffusion disponible pendant deux semaines par la suite dans la section Archives des Événements du site des investisseurs d'Inspire.
Inspire Medical Systems (NYSE: INSP) hat seine bevorstehende Teilnahme an der UBS Global Healthcare Conference bekannt gegeben. Das Medizintechnikunternehmen, das auf minimalinvasive Lösungen für obstruktive Schlafapnoe spezialisiert ist, wird am Mittwoch, den 13. November 2024, um 11:00 Uhr Eastern Time präsentieren.
Die Präsentation wird über einen Live-Stream verfügbar sein, mit Zugriff auf die Wiederholung, der zwei Wochen später im Archivbereich der Investoren-Website von Inspire verfügbar bleibt.
- None.
- None.
MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When is Inspire Medical Systems (INSP) presenting at the UBS Global Healthcare Conference 2024?
How can I watch Inspire Medical Systems' (INSP) UBS Conference presentation?
What is the main focus of Inspire Medical Systems (INSP) as presented in the announcement?
How long will the replay of INSP's UBS Conference presentation be available?
